Wednesday 22 November
The World Health Organization will host a hepatitis C drug resistance webinar on 22 November 2023 in recognition of the World Antimicrobial Resistance Awareness Week.
World Antimicrobial Resistance Awareness Week (WAAW) is a worldwide campaign that takes place every year to increase awareness and understanding of antimicrobial resistance. WAAW is organized by the Antimicrobial Resistance Division (ARM) of the World Health Organization (WHO). The campaign aims to promote best practices among the general public, One Health stakeholders, and policymakers, who all have a crucial role to play in preventing the emergence and spread of antimicrobial resistance. The Department of Global HIV, Hepatitis, and STI Programmes (HHS) has participated in WAAW since 2020 with the most relevant current HIV drug resistance topics. A novel contribution of HSS in the 2023 WAAW edition will be a workshop on awareness of hepatitis C drug resistance.
As diagnosis and treatment of hepatitis C expand to achieve global hepatitis elimination goals, we have a unique opportunity to optimise hepatitis C treatment through maximising population-level outcome and prevention and responding to possible emergence of drug-resistant hepatitis C. This webinar will advocate for a comprehensive response to viral hepatitis drug resistance. The current knowledge, research gaps and public health implications of hepatitis C drug resistance in limited settings will be reviewed. Finally, the WHO’s plan to develop an integrated Global Action Plan (GAP) linking drug resistance prevention, monitoring, and response activities at all levels for HIV, viral hepatitis and sexually transmitted infections will be presented.
Register for the webinar here.
Full details about the webinar, including the agenda, are available in the attached flyer below.